Hangzhou To Wuxi Biologics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer to halt biosimilar output in China, sell assets to WuXi Biologics
Toggle share menu
Advertisement
Pfizer to halt biosimilar output in China, sell assets to WuXi Biologics
Pfizer Inc has decided to stop producing biosimilar products in China and sell a unit in the eastern city of Hangzhou to WuXi Biologics Inc, the U.S. drugmaker said on Wednesday.
FILE PHOTO: Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S., March 2, 2021. REUTERS/Carlo Allegri
17 Mar 2021 12:25PM
Share this content
Bookmark
BEIJING: Pfizer Inc has decided to stop producing biosimilar products in China and sell a unit in the eastern city of Hangzhou to WuXi Biologics Inc, the U.S. drugmaker said on Wednesday. ....

Roxanne Liu , Kim Coghill , Miyoung Kim , Pfizer Inc , University Of Oxford , Hangzhou To Wuxi Biologics Inc , Wuxi Biologics Inc , Ryan Woo , Medical Health , ரோக்ஷ்ண்னே லியூ , கிம் கோகில் , ஃபைசர் இன்க் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ரியான் வூ , மருத்துவ ஆரோக்கியம் ,